Wegovy® Oral Pill
Powerful weight loss. Now in a pill.
The Wegovy pill is an oral GLP-1 (semaglutide) tablet for weight loss, the proven benefits of GLP-1 weight management in a convenient once-daily pill, designed to help you lose weight sustainably.
For more information on our delivery times, please click here
Fastest delivery available: Monday July 2727/07/2026
Shipping & Returns
Free, discreet next-day tracked delivery on all approved orders. Because Wegovy Pill is a prescription-only medicine, it cannot be returned once dispatched — but our support team is here seven days a week if anything isn't right.
How to use
- Wait 30 minutes before eating, drinking anything else, or taking any other oral medications.
- Take one tablet with 120ml water on an empty stomach (before breakfast) daily.
- Note: the tablet should be swallowed whole and never crushed, chewed or split.
- Check in monthly with our expert clinical team to discuss your treatment and order your next dose.
What is the Wegovy® Pill (oral GLP-1)?
The Wegovy® pill (oral semaglutide) is a prescription-only, once-daily tablet for weight loss. It is an oral GLP-1 receptor agonist, the same active ingredient as the Wegovy® injection, that mimics a natural gut hormone called GLP-1 to help control appetite and blood sugar.
This reduces hunger, lowers food cravings and supports steady, sustainable weight loss. The tablet is taken once daily, with no needles, no pens and no injections.
- Once-daily oral GLP-1 tablet
- No needles, pens or refrigeration
- Available in 1.5mg, 4mg, 9mg and 25mg doses
- Helps you feel fuller for longer
- Same active ingredient as the Wegovy® injection
- Free online consultation
Your body sets the pace
Oral semaglutide steps up gradually so your body can adjust. Your prescriber guides every dose increase, nothing changes without their sign-off.
Gentle introduction so your body begins adjusting to semaglutide.
Most people notice reduced cravings and earlier fullness.
Steadier appetite control as healthier habits start to bed in.
Long-term maintenance dose, the highest weight loss. Monthly prescriber reviews continue.
Benefits of theWegovy® Pill
A proven GLP-1 treatment, reimagined as a simple daily tablet that fits into everyday life.
Sustainable Weight Loss
Clinical trials show average weight loss of up to 16.6% over 64 weeks alongside diet and lifestyle changes, helping patients reach meaningful, long-term results.
Less Hunger, Fewer Cravings
The Wegovy pill works with your body's natural signals to reduce appetite, helping you feel fuller for longer and turn down the food noise.
A Simple Daily Tablet
No injections, needles or weekly schedules, just a daily oral GLP-1 tablet that fits into your existing routine.
Designed Around Real Life
No sharps bins, injection prep or refrigeration, giving you more flexibility at home, at work or while travelling.
Discreet and Convenient
A compact treatment that fits seamlessly into everyday life, so you can manage your weight with confidence and privacy.
Clinically-Supported Weight Care
Expert clinical guidance, ongoing support and a proven GLP-1 treatment, designed to feel more approachable and less intimidating.
Wegovy Pill vs Wegovy Injection
Both contain semaglutide and deliver clinically proven weight loss. The right choice comes down to how you'd rather take it, our prescribers can help you decide.
*Based on published OASIS 4 phase-3 trial data for oral semaglutide. **Based on STEP phase-3 trial data for the Wegovy injection. Individual results vary.
Wegovy Pill pricing
Simple monthly pricing by daily tablet dose. Every order is reviewed and approved by a UK clinician before supply.
Prices shown are per 30-tablet bottle (one month). Treatment requires clinician assessment and approval before supply.
Start my assessment →
Who is the Wegovy Pill for?
The Wegovy pill was developed to make clinically-supported weight loss more accessible to people who may have previously felt that treatment wasn't right for them. For many, the idea of self-injecting, managing needles, or fitting treatment around their lifestyle can feel overwhelming and create unnecessary barriers to getting started.
The Wegovy pill offers a modern alternative. By turning GLP-1 treatment into a simple daily tablet, it provides a more familiar, convenient way to access effective weight-management support without the practical challenges often associated with injections.
It may be particularly suitable for people who:
Verified customer reviews
Thousands of people in the UK trust Cloud Pharmacy to deliver their medication
This is definitely my most respected and is the most reliable online pharmacy I've ever used. I have never once had any concerns or issues about rules and regulations like many of the others.
Cloud pharmacy was recommended by a friend. I have been with them now for two months and have had no issues. Website contains lots of information and you can contact them easily if needed.
Fast delivery, never been disappointed with this pharmacy, great customer service very polite to deal with explains everything and sends out straight away within the 2 days, special delivery as well great people
Excellent online pharmacy. The medical questionnaire is really useful and unless there are any changes to your health, you don't have to complete it again. Ordering id easy and delivery is quick.
Wegovy Pill FAQs
Overview
The Wegovy pill is a once-daily tablet form of semaglutide, the same active ingredient that powers the familiar weekly Wegovy injection. It belongs to a class of medicines called GLP-1 receptor agonists, which work with your body's own appetite signals rather than against them. In practice, it helps you feel fuller sooner, stay satisfied for longer between meals, and naturally gravitate toward smaller portions, all of which support steady, sustained weight loss when paired with healthier eating and more movement.
What makes an oral version possible is a clever piece of formulation science. Semaglutide is a fragile peptide that stomach acid would normally destroy before it could ever reach your bloodstream. To solve this, each tablet pairs the medicine with an absorption enhancer called SNAC, which briefly shields the semaglutide and helps it cross the stomach lining intact. The result is a needle-free option that delivers comparable benefits to the injection for many people.
The pill is intended for adults living with obesity, generally meaning a BMI of 30 or above, as well as adults who are overweight with a BMI of 27 or above who also have a weight-related health condition such as type 2 diabetes, raised blood pressure, high cholesterol or obstructive sleep apnoea. People from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds may qualify at a slightly lower BMI threshold, reflecting differences in health risk.
It is a prescription-only medicine, so it is not suitable for everyone, and it is not intended for short-term or cosmetic weight loss. A clinician will always review your full medical history first to confirm it is both safe and appropriate for you before any treatment begins.
Effectiveness
In the main clinical study behind the pill (the 64-week OASIS 4 trial in adults with obesity or overweight), participants taking the 25 mg dose alongside diet and exercise lost on average around 14% of their starting body weight, compared with roughly 2.4% for those on a placebo. To put that in perspective, that is approximately 33 lb lost from an average starting weight of about 235 lb. Among people who stayed on treatment throughout and took it consistently, the average rose to roughly 16–17%.
It is worth keeping expectations grounded, as individual results vary considerably. The breakdown of results from the study was as follows:
| Amount of body weight lost | Proportion of people on the Wegovy pill |
|---|---|
| 5% or more | About 76% (roughly 8 in 10) |
| 10% or more | About 6 in 10 |
| 20% or more | About 28% (roughly 1 in 4) |
A smaller group respond less strongly. The medicine is a tool that works best when it supports genuine lifestyle change, not a substitute for it.
There is no single timeline that fits everyone, because people respond to semaglutide at different rates. That said, many people notice their appetite beginning to shift within the first few weeks, often as reduced hunger or feeling satisfied with less food. Visible changes on the scales typically build more gradually as the dose increases over the first few months.
Because the dose is deliberately raised in stages, the fuller effect tends to emerge once you reach the maintenance dose rather than at the very start. Patience matters here. Steady, gradual loss is both expected and healthier than rapid drops, and your prescriber can give you a more personalised sense of what is realistic for your circumstances.
Directions of Use
Timing and technique genuinely matter with this tablet, more so than with most medicines. Follow these steps every morning:
- Take it first thing in the morning on a completely empty stomach, the moment you wake.
- Swallow the tablet whole with no more than a small sip of plain water (around 120 ml). Do not use coffee, juice, sparkling or hot water.
- Do not crush, chew or split the tablet.
- Wait at least 30 minutes before eating, drinking anything else, or taking any other tablets or supplements.
- Try to take it at the same time each day so it becomes a settled routine.
That 30-minute window is the single most important habit to get right. The SNAC absorption system only works properly when your stomach is empty and undiluted, so food, drink or other medicines taken too soon can substantially reduce how much semaglutide your body absorbs, or stop it working altogether. A simple trick many people use is to keep the tablet and a glass of water on the bedside table, take it before anything else, then use the 30 minutes to shower or get ready before breakfast.
Slip-ups happen, and the rules for getting back on track safely are simple:
- If you miss a dose, skip it entirely and carry on with your next tablet the following morning as normal.
- Do not take the missed tablet later in the day, and never double up to compensate, as this only raises the risk of side effects without improving results.
- If you vomit shortly after taking your tablet, do not take a replacement dose that day. Resume your usual routine the next morning.
- If you find you are missing several doses in a row, or you are unsure how to proceed, check in with your prescriber before continuing.
Dosage & Titration
The Wegovy pill is introduced gradually using a process called titration, which simply means starting low and stepping up slowly. This staged approach gives your digestive system time to adjust and is the main reason side effects tend to settle rather than build. A typical schedule looks like this:
| Dose | When | Notes |
|---|---|---|
| 1.5 mg once daily | Days 1–30 (month one) | Starting dose |
| 4 mg once daily | Days 31–60 (month two) | Titration step |
| 9 mg once daily | Days 61–90 (month three) | Titration step |
| 25 mg once daily | Day 91 onwards | Maintenance dose |
Crucially, the schedule is a guide rather than a race. Your prescriber will only move you up once you are comfortably tolerating your current dose, and not everyone needs to reach the full 25 mg to see meaningful results. If a particular step proves difficult, they may hold you at a lower dose for longer, step you back down, or discuss alternatives. The 25 mg dose is designed for ongoing, long-term use once reached.
Ingredients
The active ingredient is semaglutide, a GLP-1 receptor agonist that closely mimics a natural gut hormone your body releases after eating. By activating GLP-1 receptors, including those in the appetite-regulating regions of the brain, it dampens hunger, curbs cravings and slows the rate at which your stomach empties, all of which help you eat less without feeling deprived.
Alongside the semaglutide, each tablet contains a small number of inactive ingredients. The most important of these is salcaprozate sodium, better known as SNAC, the absorption enhancer that allows the semaglutide to survive the stomach and pass into the bloodstream. The tablets also contain magnesium stearate, a common manufacturing aid. The semaglutide content itself varies by strength across the 1.5 mg, 4 mg, 9 mg and 25 mg tablets.
Side Effects
The most frequently reported side effects are digestive, and they mirror those seen with the injectable form. Nausea is usually the first to appear, often within the first few days of starting or stepping up a dose, and is also commonly the first to ease. Other common effects include:
- Vomiting, diarrhoea and constipation
- Stomach pain and bloating
- Heartburn and belching
- Headache, tiredness and dizziness
For most people these are mild to moderate and tend to improve as the body adjusts, which is precisely why the dose is increased so gradually. Simple measures help a great deal: eating smaller, plainer meals, avoiding very fatty or spicy food, not lying down straight after eating, staying well hydrated, and increasing fibre for constipation can all reduce discomfort. Some people notice hair thinning, but this is usually linked to rapid weight loss rather than the medicine itself and typically recovers once weight stabilises. If symptoms are persistent or troubling, your prescriber can adjust your schedule.
Serious side effects are uncommon, but a few warrant prompt attention rather than waiting to see if they pass:
- Pancreatitis: severe stomach pain that spreads to the back, with or without vomiting, needs urgent medical assessment.
- Gallbladder problems: including gallstones, which may show as upper-right abdominal pain, fever, jaundice or pale stools.
- Low blood sugar: a higher risk for people who also take diabetes medicines such as insulin or sulfonylureas.
- Dehydration: persistent vomiting or diarrhoea can lead to dehydration and, in turn, strain the kidneys, so staying well hydrated is important.
- Serious allergic reaction: seek emergency help for swelling of the face, lips, tongue or throat, or difficulty breathing.
As a general rule, anything severe, persistent or simply worrying is worth flagging to a clinician early.
This section touches on health matters that can feel sensitive. If you are weighing up treatment, your prescriber or pharmacist is the right person to talk through your individual risks.
Warnings
Some people should avoid it entirely. You should not take the Wegovy pill if any of the following apply:
- You or a close family member has ever had medullary thyroid carcinoma (MTC), a specific type of thyroid cancer.
- You have the genetic condition Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You have had a serious allergic reaction to semaglutide or any of the tablet's ingredients.
- You are pregnant, trying to conceive, or breastfeeding. As a precaution, GLP-1 medicines are generally stopped at least two months before planned conception.
Beyond these, certain conditions call for careful discussion with your prescriber rather than an outright no, including a history of pancreatitis, severe gastrointestinal disease such as gastroparesis, significant kidney or liver problems, gallbladder issues, type 1 diabetes, or diabetic eye disease (retinopathy). The pill should also never be combined with other semaglutide products or any other GLP-1 medicine. It is not licensed for anyone under 18.
It can, and this is an important conversation to have before starting. Because semaglutide slows down how quickly your stomach empties, it can change the speed at which other oral medicines are absorbed. Medicines that depend on precise, consistent levels in the blood, such as certain thyroid treatments, blood thinners, some epilepsy medicines and certain immunosuppressants, may need closer monitoring or adjusted timing.
There is also a practical scheduling point. Any other morning medication should be taken only after your 30-minute fasting window has passed, never alongside the Wegovy pill. Always give your prescriber a complete list of everything you take, including over-the-counter products, vitamins and supplements, so they can check for interactions and advise on timing.
Availability & Delivery
The Wegovy pill received MHRA approval for weight management in the UK on 11 June 2026, making it the first GLP-1 weight-loss tablet licensed in this country. However, regulatory approval and shop-shelf availability are two separate milestones. At launch, the most likely route to access is through regulated private pharmacy services, much as happened with the injectable treatments, with NHS availability dependent on a separate cost-effectiveness review that has not yet concluded.
When it does become available, the pathway is straightforward and entirely online for most providers: you complete a clinical consultation, a UK-registered prescriber reviews whether the pill is suitable for you, and an approved order is dispensed and delivered discreetly to your door. A genuine advantage over the injection is convenience in handling, as the tablets do not need refrigeration and produce no sharps waste. Always use a GPhC-registered pharmacy, and never buy from any site that skips a proper consultation or offers to import it from abroad.
Final UK pricing is still being confirmed, so any figures circulating now are indicative rather than fixed. Early private-market estimates place the starting doses broadly in line with the weekly Wegovy injection, with prices rising at the higher maintenance dose, very roughly in the region of £99 to £200 per month depending on the dose and provider. Because cost scales with dose, the lower titration doses in your first weeks tend to be cheaper than the 25 mg maintenance dose.
For a clearer picture, it is worth comparing against current options: the Wegovy and Mounjaro injections both sit in a comparable private price range. Pricing is reviewed regularly and varies between providers, so confirm the current figure with your chosen provider before committing.
Alternatives
There are several well-established alternatives, and the best choice depends on your goals, your tolerance for needles and how much weight you are aiming to lose. The table below gives an at-a-glance comparison:
| Treatment | Format | Key difference |
|---|---|---|
| Wegovy injection | Weekly injection | Same semaglutide as the pill, with broadly similar results |
| Mounjaro (tirzepatide) | Weekly injection | Works on two appetite pathways; tends to give the greatest average weight loss |
| Saxenda (liraglutide) | Daily injection | Generally less potent than the newer treatments |
| Foundayo (orforglipron) | Daily tablet | No 30-minute fast needed; slightly less weight loss than the Wegovy pill |
| Orlistat | Capsule (with meals) | Older option that blocks some dietary fat; lower strength available without prescription |
| Rybelsus | Daily tablet | Also semaglutide, but licensed only for type 2 diabetes, not weight loss |
If you specifically prefer a tablet, the picture is more nuanced. Foundayo can be taken with food and without the 30-minute fasting window, though trial data suggests slightly less weight loss than the Wegovy pill. It is worth noting that Rybelsus, despite containing the same active ingredient, is not a like-for-like substitute because of its different licence and lower dose. A consultation is the right way to weigh these options up against your individual circumstances.
Patient Information Leaflet
The Patient Information Leaflet (PIL) and the more detailed Summary of Product Characteristics (SmPC) are the definitive, regulator-approved sources for how to use the medicine safely, and they should always take precedence over any website summary, including this one. In the UK, these documents are published on the MHRA's products website and are usually available shortly after a medicine's approval. A printed copy of the leaflet is also included inside every pack dispensed to you.
It is well worth reading the leaflet in full before your first dose, as it carries the most complete and current detail on dosing, storage, interactions and warnings. If anything is unclear, your pharmacist can talk it through with you. Should you experience a side effect, you can also report it through the MHRA's Yellow Card scheme, which helps monitor medicine safety across the UK.
A fully qualified team
Our experienced pharmacists are all registered with the General Pharmaceutical Council in the UK.
Confirm Wegovy® Oral Pill treatment selection
| 1.5mg | 30 | £99.00 |
| 4mg | 30 | £105.00 |
| 9mg | 30 | £125.00 |
| 25mg | 30 | £179.00 |
